ALFA Filings
Every announcement, straight from the exchange
Every Aurobindo Pharma product launch announcement on NSE and BSE, newest first, each with its own page.
Time
2 announcements
Acrotech Biopharma launched ADQUEY (difamilast 1% ointment) in the U.S. and established a dedicated dermatology business unit to support this market entry.
Aurobindo Pharma's subsidiary, Lannett Company LLC, launched the generic version of Advair Diskus® in the US. This marks the company's first commercialized product from its inhalation pipeline.